66 related articles for article (PubMed ID: 9816083)
1. Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918.
Witherspoon SM; Emerson DL; Kerr BM; Lloyd TL; Dalton WS; Wissel PS
Clin Cancer Res; 1996 Jan; 2(1):7-12. PubMed ID: 9816083
[TBL] [Abstract][Full Text] [Related]
2. Sensitive and rapid bioassay for analysis of P-glycoprotein-inhibiting activity of chemosensitizers in patient serum.
Lehnert M; de Giuli R; Twentyman PR
Clin Cancer Res; 1996 Feb; 2(2):403-10. PubMed ID: 9816184
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918.
Wallstab A; Koester M; Böhme M; Keppler D
Br J Cancer; 1999 Mar; 79(7-8):1053-60. PubMed ID: 10098736
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of XR9576 in healthy volunteers demonstrates modulation of P-glycoprotein in CD56+ lymphocytes after oral and intravenous administration.
Stewart A; Steiner J; Mellows G; Laguda B; Norris D; Bevan P
Clin Cancer Res; 2000 Nov; 6(11):4186-91. PubMed ID: 11106230
[TBL] [Abstract][Full Text] [Related]
5. The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells.
Traunecker HC; Stevens MC; Kerr DJ; Ferry DR
Br J Cancer; 1999 Nov; 81(6):942-51. PubMed ID: 10576649
[TBL] [Abstract][Full Text] [Related]
6. Effect of the multidrug inhibitor GG918 on drug sensitivity of human leukemic cells.
Zhou DC; Simonin G; Faussat AM; Zittoun R; Marie JP
Leukemia; 1997 Sep; 11(9):1516-22. PubMed ID: 9305607
[TBL] [Abstract][Full Text] [Related]
7. Interaction of rhodamine 123 with living cells studied by flow cytometry.
Darzynkiewicz Z; Traganos F; Staiano-Coico L; Kapuscinski J; Melamed MR
Cancer Res; 1982 Mar; 42(3):799-806. PubMed ID: 7059978
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport.
Evers R; Kool M; Smith AJ; van Deemter L; de Haas M; Borst P
Br J Cancer; 2000 Aug; 83(3):366-74. PubMed ID: 10917553
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
Wong HL; Bendayan R; Rauth AM; Wu XY
J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
[TBL] [Abstract][Full Text] [Related]
10. Measurement of basal, substrate induced and total P-glycoprotein activity in bronchoalveolar lavage T-cell subsets.
Donnenberg VS; Wilson JW; Burckart GJ; Zeevi A; Iacono A; Donnenberg AD
Cytometry A; 2004 Feb; 57(2):75-85. PubMed ID: 14750128
[TBL] [Abstract][Full Text] [Related]
11. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
12. CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
Raspadori D; Damiani D; Michieli M; Stocchi R; Gentili S; Gozzetti A; Masolini P; Michelutti A; Geromin A; Fanin R; Lauria F
Haematologica; 2002 Nov; 87(11):1135-40. PubMed ID: 12414342
[TBL] [Abstract][Full Text] [Related]
13. Scanning microspectrofluorometry of rhodamine 123 in multidrug-resistant cells.
Millot JM; Sharonov S; Manfait M
Cytometry; 1994 Sep; 17(1):50-8. PubMed ID: 8001458
[TBL] [Abstract][Full Text] [Related]
14. Alterations in respiration rate of isolated rainbow trout hepatocytes exposed to the P-glycoprotein substrate rhodamine 123.
Bains OS; Kennedy CJ
Toxicology; 2005 Oct; 214(1-2):87-98. PubMed ID: 16026915
[TBL] [Abstract][Full Text] [Related]
15. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.
Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
Drug Metab Dispos; 1999 Jul; 27(7):827-34. PubMed ID: 10383928
[TBL] [Abstract][Full Text] [Related]
16. In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumors.
Muzzammil T; Moore MJ; Ballinger JR
Cancer Biother Radiopharm; 2000 Aug; 15(4):339-46. PubMed ID: 11041018
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo correlation of hepatic transporter effects on erythromycin metabolism: characterizing the importance of transporter-enzyme interplay.
Lam JL; Okochi H; Huang Y; Benet LZ
Drug Metab Dispos; 2006 Aug; 34(8):1336-44. PubMed ID: 16698890
[TBL] [Abstract][Full Text] [Related]
18. Expression of the neural cell adhesion molecule CD56 is not associated with P-glycoprotein overexpression in core-binding factor acute myeloid leukemia.
Suvannasankha A; Minderman H; O'Loughlin KL; Sait SN; Stewart CC; Greco WR; Baer MR
Leuk Res; 2004 May; 28(5):449-55. PubMed ID: 15068897
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice.
Park S; Sinko PJ
J Pharmacol Exp Ther; 2005 Mar; 312(3):1249-56. PubMed ID: 15528451
[TBL] [Abstract][Full Text] [Related]
20. Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.
Bardelmeijer HA; Beijnen JH; Brouwer KR; Rosing H; Nooijen WJ; Schellens JH; van Tellingen O
Clin Cancer Res; 2000 Nov; 6(11):4416-21. PubMed ID: 11106262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
